Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06232447 · ClinicalTrials.gov registry record · NA

Menthol, Inflammation, and Nicotine Transition Study

A NA study of Cigarette Smoking and Inflammatory Response, sponsored by Rosalind Franklin University of Medicine and Science.

Recruiting
Registry status
NA
Development phase
68
Enrollment target
1
Study location

NCT06232447 is a NA study of Cigarette Smoking and Inflammatory Response that is actively recruiting participants, run by Rosalind Franklin University of Medicine and Science. The registered enrollment target is 68 participants, below the 175-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06232447, a NA study of Cigarette Smoking and Inflammatory Response, is actively recruiting participants, sponsored by Rosalind Franklin University of Medicine and Science.

RECRUITING
Registry status
NA
Development phase
68 participants
Enrollment target
1
Study location

Study Summary

This study will focus on examining the potential impact of menthol flavoring in cigarettes on biomarkers of systemic inflammation as a subclinical indicator of cardiovascular disease risk.

Interventions

  • OTHER Cigarette Type Switching

Study Locations (1)

Illinois

  • Rosalind Franklin University of Medicine and Science - North Chicago

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2024-03-26
Est. Completion 2026-06
Phase NA

What the Registry Record Tells You About NCT06232447

The ClinicalTrials.gov registry entry for NCT06232447 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 175-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (61% lower). The listed sponsor is Rosalind Franklin University of Medicine and Science, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cigarette Smoking appearing as the primary indexed condition, and to 1 intervention - of which Cigarette Type Switching is the first listed.

NCT06232447 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06232447 about?

NCT06232447 is a clinical study titled "Menthol, Inflammation, and Nicotine Transition Study". This study will focus on examining the potential impact of menthol flavoring in cigarettes on biomarkers of systemic inflammation as a subclinical indicator of cardiovascular disease risk.

What is the current status of trial NCT06232447?

This trial is currently recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2024-03-26. Estimated completion is 2026-06.

What conditions does trial NCT06232447 study?

This clinical trial studies the following conditions: Cigarette Smoking, Inflammatory Response.

What interventions are being tested in trial NCT06232447?

The interventions under investigation include: Cigarette Type Switching (OTHER).

Who is sponsoring clinical trial NCT06232447?

This trial is sponsored by Rosalind Franklin University of Medicine and Science, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06232447 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cigarette Smoking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.